Life sciences-focused cloud startup Benchling has seen its business soar over the last few years, amid a renewed interest in biotech among investors. Benchling CEO Sajith Wickramasekara joins Caroline Hyde and Ed Ludlow to discuss the state of the global biopharma industry and its adoption of technology. He speaks on "Bloomberg Technology."
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
https://www.youtube.com/channel/UCrM7B7SL_g1edFOnmj-SDKg
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here: https://tinyurl.com/ycyevxda
Get the latest in tech from Silicon Valley and around the world here:
https://www.bloomberg.com/technology
Connect with us on...
Twitter: https://twitter.com/technology
Facebook: https://www.facebook.com/BloombergTechnology
Instagram: https://www.instagram.com/bloombergbusiness/
